Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial
No hidden fees or confusing pricing Direct access to dedicated treatment specialists Fast, transparent prescription and consultation process Flexible, no-commitment treatment plans "Weekly shots gave me steady energy and no afternoon slump." "I feel lighter, more active, and less sluggish." "Energy picked up and my workouts stopped dragging." "Metabolism felt smoother and my focus improved." "I am not crashing mid day anymore." "Easy injection and energy that actually lasts." "Clean boost without jitters or caffeine." "Helped kick my lethargy and get me moving." "I finally feel like doing things after work again." "Energy plus motivationexactly what I needed." Support fat metabolism Lipotropics move fat and bile from the liver, supporting fat metabolism and liver health
Disclosures: Nicholas Prescott: Nothing to Disclose, Andres Mansisidor: Nothing to Disclose, Yaron Bram: Nothing to Disclose, Christine Lim: Nothing to Disclose, Viviana Risca: Nothing to Disclose, Yael David: Nothing to Disclose, Robert Schwartz: Miromatrix Inc: Advisor, Lime Therapeutics: Advisor, Otsuka Inc.: Grant/Research Support, Alnylam Pharmaceuticals: Speaking and Teaching, Alnylam Pharmaceuticals: Consultant 722 IMPROVEMENTS IN PRURITUS ARE ASSOCIATED WITH IMPROVEMENTS IN GROWTH IN PATIENTS WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS: DATA FROM THE MARCH-ON TRIAL Alexander Miethke 1 Amal Aqul 2 Chuan-Hao Lin 3 Douglas Mogul 4 Tiago Nunes 4 Jolan Terner-Rosenthal 4 Marshall Baek 4 Pamela Vig 4 Richard Thompson 5 , 1 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 2 University of Texas Southwestern Medical Center, Dallas, Texas, 3 Children's Hospital Los Angeles, Los Angeles, California, 4 Mirum Pharmaceuticals, Inc., Foster City, California, 5 King's College London, United Kingdom Background: Progressive familial intrahepatic cholestasis (PFIC) is a group of disorders resulting in disrupted bile composition and cholestasis leading to debilitating pruritus, growth deficits, vitamin deficiency, and progressive liver damage
Barry Conrad Are really, you know what, because listeners, Mel and I had, we talked on Instagram about this, but she was like, what will we do if you don't like sitting in the front row
